Invacare, a maker of wheelchairs, crutches and motorized scooters, said that Doug Newlin, senior vice president of global engineering, will assume leadership of the company's regulatory team in place of Colleen Craven, chief compliance officer, who has resigned for personal reasons.

Newlin has experience working with the Food & Drug Administration from his time at Fenwal. In his role there as senior vice president of research and development, his functional responsibilities included regulatory and medical affairs.